Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 8/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | BCL2 | P10415 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4324585 | 1.00 | TYMS (0.41) | TYMSALOX15TDP1BCL2ALDH1A1 | |
| SCHEMBL29580210 | 1.00 | TYMS (0.41) | TYMSALOX15TDP1BCL2ALDH1A1 | |
| SCHEMBL12744266 | 0.95 | TYMS (0.40) | TYMSALOX15TDP1BCL2ALDH1A1 | |
| SCHEMBL14290229 | 0.91 | TYMS (0.35) | TYMSALOX15TDP1BCL2 | |
| SCHEMBL13590977 | 0.88 | TYMS (0.33) | TYMSMEN1POLBKMT2A | |
| SCHEMBL27316637 | 0.86 | TYMS (0.34) | TYMSBCL2MEN1POLBKMT2A | |
| SCHEMBL2785738 | 0.84 | TYMS (0.50) | TYMSTDP1ALDH1A1MEN1POLB | |
| SCHEMBL3077539 | 0.84 | TYMS (0.50) | TYMSTDP1BCL2ALDH1A1MEN1 | |
| SCHEMBL17929970 | 0.83 | TYMS (0.40) | TYMS | |
| SCHEMBL1188564 | 0.81 | TYMS (0.41) | TYMSALOX15TDP1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035579-A1 | RYLENE-BASED UV CURABLE SECURITY INK COMPOSITIONS | SICPA HOLDING SA (CH) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035579-A1 | RYLENE-BASED UV CURABLE SECURITY INK COMPOSITIONS | RB1, CDK1, MARK1 | TYMS 2827/4885ALOX15 3280/4885TDP1 3044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.